FPR Agonist 43

FPR Agonist 43 is an agonist of TNF-alpha used in studies of NF-kB Signaling and Immune Signaling and related signaling programs. It is especially relevant in immunology and inflammation models, where defined compound exposure can be linked to inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses.

By activating TNF-alpha, FPR Agonist 43 can be used to examine inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses. The immunomodulator annotation adds relevance to immune-cell activation, cytokine, and mediator assays, together with downstream-response mapping in the same experimental setting. In immunology and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving TNF-alpha
• Pathway perturbation studies connected to NF-kB Signaling and Immune Signaling and related signaling programs
• Agonist-response and downstream signaling studies
• Immune-cell activation, cytokine, and mediator assays

Overall, FPR Agonist 43 is appropriate when a defined chemical perturbant is needed to connect TNF-alpha with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in immunology and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.